Literature DB >> 22942258

Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy.

Rupal Ramakrishnan1, Chun Huang, Hyun-Il Cho, Mark Lloyd, Joseph Johnson, Xiubao Ren, Soner Altiok, Daniel Sullivan, Jeffrey Weber, Esteban Celis, Dmitry I Gabrilovich.   

Abstract

Autophagy attenuates the efficacy of conventional chemotherapy but its effects on immunotherapy have been little studied. Here, we report that chemotherapy renders tumor cells more susceptible to lysis by CTL in vivo. Moreover, bystander tumor cells that did not express antigen were killed by CTL. This effect was mediated by transient but dramatic upregulation of the mannose-6-phosphate receptor (MPR) on the tumor cell surface. Antitumor effects of combined treatment related to the kinetics of MPR upregulation and abrogation of this event abolished the combined effect of immunotherapy and chemotherapy. MPR accumulation on the tumor cell surface during chemotherapy was observed in different mouse tumor models and in patients with multiple myeloma. Notably, this effect was the result of redistribution of the receptor caused by chemotherapy-inducible autophagy. Together, our findings reveal one molecular mechanism through which the antitumor effects of conventional cancer chemotherapy and immunotherapy are realized. 2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22942258      PMCID: PMC4577568          DOI: 10.1158/0008-5472.CAN-12-2236

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  Immunological aspects of cancer chemotherapy.

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 2.  Apoptosis induced by the lymphocyte effector molecule perforin.

Authors:  Paul Bolitho; Ilia Voskoboinik; Joseph A Trapani; Mark J Smyth
Journal:  Curr Opin Immunol       Date:  2007-04-17       Impact factor: 7.486

3.  Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.

Authors:  D Behl; L F Porrata; S N Markovic; L Letendre; R K Pruthi; C C Hook; A Tefferi; M A Elliot; S H Kaufmann; R A Mesa; M R Litzow
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

4.  A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

Authors:  Philip M Arlen; James L Gulley; Catherine Parker; Lisa Skarupa; Mary Pazdur; Dennis Panicali; Patricia Beetham; Kwong Y Tsang; Douglas W Grosenbach; Jarett Feldman; Seth M Steinberg; Elizabeth Jones; Clara Chen; Jennifer Marte; Jeffrey Schlom; William Dahut
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 5.  The roles of therapy-induced autophagy and necrosis in cancer treatment.

Authors:  Ravi K Amaravadi; Craig B Thompson
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

Review 6.  Combined modality immunotherapy and chemotherapy: a new perspective.

Authors:  Rupal Ramakrishnan; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2008-05-17       Impact factor: 6.968

7.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

8.  Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.

Authors:  Scott J Antonia; Noweeda Mirza; Ingo Fricke; Alberto Chiappori; Patricia Thompson; Nicholas Williams; Gerold Bepler; George Simon; William Janssen; Ji-Hyun Lee; Kerstin Menander; Sunil Chada; Dmitry I Gabrilovich
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

9.  Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.

Authors:  Natalie J Ives; Rebecca L Stowe; Paul Lorigan; Keith Wheatley
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

Review 10.  Cancer vaccines: moving beyond current paradigms.

Authors:  Jeffrey Schlom; Philip M Arlen; James L Gulley
Journal:  Clin Cancer Res       Date:  2007-07-01       Impact factor: 12.531

View more
  34 in total

1.  BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells.

Authors:  Cigdem Atay; Taekyoung Kwak; Sergio Lavilla-Alonso; Laxminarasimha Donthireddy; Allison Richards; Valerie Moberg; Shari Pilon-Thomas; Michael Schell; Jane L Messina; Vito W Rebecca; Min Xiao; Jiufeng Tan; Gao Zhang; Jeffrey S Weber; Meenhard Herlyn; Amod A Sarnaik; Dmitry I Gabrilovich
Journal:  Clin Cancer Res       Date:  2019-02-14       Impact factor: 12.531

Review 2.  Mannose-6-phosphate receptor: a novel regulator of T cell immunity.

Authors:  Anjuman Ara; Khawaja Ashfaque Ahmed; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2018-05-16       Impact factor: 11.530

Review 3.  Emerging strategies to effectively target autophagy in cancer.

Authors:  V W Rebecca; R K Amaravadi
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

4.  HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC.

Authors:  Jie Han; Leslie A Goldstein; Wen Hou; Suman Chatterjee; Timothy F Burns; Hannah Rabinowich
Journal:  Autophagy       Date:  2018-03-21       Impact factor: 16.016

5.  Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells.

Authors:  Xuchen Cao; Bowen Liu; Wenfeng Cao; Weiran Zhang; Fei Zhang; Hongmeng Zhao; Ran Meng; Lin Zhang; Ruifang Niu; Xishan Hao; Bin Zhang
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

6.  Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice.

Authors:  Sungjune Kim; Rupal Ramakrishnan; Sergio Lavilla-Alonso; Prakash Chinnaiyan; Nikhil Rao; Erin Fowler; John Heine; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2014-06-19       Impact factor: 6.968

Review 7.  Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.

Authors:  Junjie Wu; David J Waxman
Journal:  Cancer Lett       Date:  2018-04-10       Impact factor: 8.679

Review 8.  Autophagy in blood cancers: biological role and therapeutic implications.

Authors:  Alessio Nencioni; Michele Cea; Fabrizio Montecucco; Valter D Longo; Franco Patrone; Angelo M Carella; Tessa L Holyoake; G Vignir Helgason
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

Review 9.  The potential of CAR T cell therapy for prostate cancer.

Authors:  Philipp Wolf; Jamal Alzubi; Christian Gratzke; Toni Cathomen
Journal:  Nat Rev Urol       Date:  2021-07-08       Impact factor: 14.432

10.  Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study.

Authors:  Ya Chen; Yanan Wang; Zhengyu Yang; Minjuan Hu; Yanwei Zhang; Fangfei Qian; Wei Zhang; Bo Zhang; Baohui Han
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.